These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1585 related items for PubMed ID: 9222550

  • 21. Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension.
    Sventek P, Turgeon A, García R, Schiffrin EL.
    J Hypertens; 1996 Jan; 14(1):57-64. PubMed ID: 12013496
    [Abstract] [Full Text] [Related]

  • 22. Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats.
    Li JS, Knafo L, Turgeon A, Garcia R, Schiffrin EL.
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H88-93. PubMed ID: 8760162
    [Abstract] [Full Text] [Related]

  • 23. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S, Takeyama K, Fukuya F, Nagai R, Hosoki K, Nishimura K, Deguchi T, Karasawa T.
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [Abstract] [Full Text] [Related]

  • 24. Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954.
    Ikeda T, Ohta H, Okada M, Kawai N, Nakao R, Siegl PK, Kobayashi T, Miyauchi T, Nishikibe M.
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S337-41. PubMed ID: 11078414
    [Abstract] [Full Text] [Related]

  • 25. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
    Johnson RJ, Galligan JJ, Fink GD.
    J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813
    [Abstract] [Full Text] [Related]

  • 26. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
    Ehmke H, Faulhaber J, Münter K, Kirchengast M, Wiesner RJ.
    Hypertension; 1999 Apr; 33(4):954-60. PubMed ID: 10205230
    [Abstract] [Full Text] [Related]

  • 27. Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
    Li JS, Sventek P, Schiffrin EL.
    J Hypertens; 1996 Nov; 14(11):1331-9. PubMed ID: 8934362
    [Abstract] [Full Text] [Related]

  • 28. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R, Tagawa T, Ishida T, Naruse T.
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [Abstract] [Full Text] [Related]

  • 29. BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension.
    Douglas SA, Gellai M, Ezekiel M, Ohlstein EH.
    J Hypertens; 1994 May; 12(5):561-7. PubMed ID: 7930556
    [Abstract] [Full Text] [Related]

  • 30. Different activation of vascular mitogen-activated protein kinases in spontaneously and DOCA-salt hypertensive rats.
    Kubo T, Ibusuki T, Saito E, Kambe T, Hagiwara Y.
    Eur J Pharmacol; 2000 Jul 21; 400(2-3):231-7. PubMed ID: 10988339
    [Abstract] [Full Text] [Related]

  • 31. Effects of endothelin ETA receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure.
    Xia QG, Reinecke A, Dorenkamp M, Daemen MJ, Simon R, Unger T.
    Acta Pharmacol Sin; 2006 Nov 21; 27(11):1417-22. PubMed ID: 17049116
    [Abstract] [Full Text] [Related]

  • 32. A role for endothelin ETA receptors in regulation of renal function in spontaneously hypertensive rats.
    Bird JE, Webb ML, Giancarli MR, Chao C, Dorso CR, Asaad MM.
    Eur J Pharmacol; 1995 Dec 27; 294(1):183-9. PubMed ID: 8788430
    [Abstract] [Full Text] [Related]

  • 33. Significance of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats: renal and hemodynamic effects of endothelin receptor antagonists.
    Hocher B, Rohmeiss P, Zart R, Diekmann F, Vogt V, Metz D, Fakhury M, Gretz N, Bauer C, Koppenhagen K.
    J Cardiovasc Pharmacol; 1995 Dec 27; 26 Suppl 3():S470-2. PubMed ID: 8587449
    [Abstract] [Full Text] [Related]

  • 34. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
    Li JS, Larivière R, Schiffrin EL.
    Hypertension; 1994 Aug 27; 24(2):183-8. PubMed ID: 8039842
    [Abstract] [Full Text] [Related]

  • 35. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL, Larivière R, Li JS, Sventek P.
    J Vasc Res; 1996 Aug 27; 33(3):235-48. PubMed ID: 8924521
    [Abstract] [Full Text] [Related]

  • 36. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
    Matsumura Y, Fujita K, Miyazaki Y, Takaoka M, Morimoto S.
    J Cardiovasc Pharmacol; 1995 Aug 27; 26 Suppl 3():S456-8. PubMed ID: 8587444
    [Abstract] [Full Text] [Related]

  • 37. Antihypertensive effects of a novel endothelin-A receptor antagonist in rats.
    Bird JE, Moreland S, Waldron TL, Powell JR.
    Hypertension; 1995 Jun 27; 25(6):1191-5. PubMed ID: 7768562
    [Abstract] [Full Text] [Related]

  • 38. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Hashimoto N, Takaoka M, Morimoto S.
    Life Sci; 1996 Jun 27; 58(1):PL1-7. PubMed ID: 8628104
    [Abstract] [Full Text] [Related]

  • 39. Hemodynamic effects of a selective endothelin--a receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats.
    Yu M, Gopalakrishnan V, McNeill JR.
    J Cardiovasc Pharmacol; 1998 Jun 27; 31 Suppl 1():S262-4. PubMed ID: 9595455
    [Abstract] [Full Text] [Related]

  • 40. Tonic action of endothelin type B and dopamine D3 receptors in spontaneously hypertensive and deoxycorticosterone acetate-salt hypertensive rats: effects of intrarenally applied selective antagonists.
    Badzynska B, Baranowska I, Sadowski J.
    J Physiol Pharmacol; 2024 Feb 27; 75(1):. PubMed ID: 38583435
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 80.